Ann-Muriel Steff

Ann-Muriel Steff is a seasoned professional in the field of research and development, currently serving as Project Leader at the Coalition for Epidemic Preparedness Innovations (CEPI) since January 2023. Prior experience includes roles at GSK spanning over a decade, where Ann-Muriel held various leadership positions in vaccine research, including Head of Preclinical R&D at the GSK Rockville Center and Director of Discovery Projects. Additionally, Ann-Muriel has worked as a Senior Research Scientist at Charles River Laboratories and led the Immunology department at CiToxLAB North America Inc. Other notable experience includes managing research at the World Anti-Doping Agency and heading the Bioassays Unit at Procrea BioSciences. Ann-Muriel's academic background comprises a PhD in Biochemistry and Cellular Biology from Université Montpellier 2 and a PharmD from the University of Montpellier.